print Biosciences Litigation
Fulbright & Jaworski's Biosciences Litigation Practice ranks among the largest, most technologically capable and experienced sections in the country devoted to bioscience and chemical technology and patent litigation.
Questions about a bioscience matter?
Contact David Parker or Tom Paul.
Complemented by the biotechnology and chemical practice section of Fulbright's Intellectual Property and Technology Practice, our Biosciences Litigation Practice includes a team of highly experienced lawyers as well as technical advisors.
Reflecting this group's tremendous understanding of the topic, many of our lawyers and all of our technical advisors have specialized training and extensive hands-on experience in:
- Gene therapy
- Gene cloning
- Agricultural biotechnology
- Genomic analysis
- Genomic reagents
- Immunology
- Pharmaceutics
- Pharmacogenomics
- Virology
- Medical therapy
- Medical devices
Download Fulbright’s
6th Annual Litigation Trends
Survey Report
Fulbright's Biosciences Litigation Practice represents major pharmaceutical, chemical, agricultural, seed, and biotechnology companies and universities in both jury and bench trial cases. Our track record clearly demonstrates Fulbright's excellence in presenting complex cases in a manner that judges and juries understand, and with minimum disruption to our clients' day-to-day operations.
For further information or questions about Fulbright's biosciences practice, please contact David Parker or Tom Paul.
Awards
- For the fifth year, Fulbright is one of the top twenty trademark firms in U.S. (Intellectual Property Today, May 2006) More . . .
- Fulbright Texas technology lawyers gained accolades from Chambers U.S.A. 2006. More . . .
- Fulbright’s IP Litigation Group ranked one of the ten most active in the U.S. (IP Law Bulletin, October 2005) More . . .
- A "Top Patent Defense Firm" for IP litigation matters (The American Lawyer, 2004).
When You Think BIOSCIENCE LITIGATION, Think Fulbright.™
